NCT05636371: WRITE

Written Communication in the Intensive Care Unit

Completed NA Last updated 31 August 2023

What this trial tests

NA trial testing Written Communication in Communication in 166 participants. Completed in 1 July 2023.

Timeline

1 November 2022

Primary endpoint
19 May 2023

1 July 2023

Quick facts

Lead sponsor	Rush University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	166
Start date	1 November 2022
Primary completion	19 May 2023
Estimated completion	1 July 2023
Sites	1 location across United States

Drugs / interventions tested

• Written Communication

Conditions studied

• Communication — all drugs for Communication →
• Satisfaction, Patient — all drugs for Satisfaction, Patient →
• Burnout — all drugs for Burnout →

Sponsor

Rush University Medical Center

Who can join

18 and older, any sex, with Communication or Satisfaction, Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to compare the experience of intensive care unit (ICU) families and care providers before and after the implementation of an approach whereby clinicians initiate written communication with families

The main questions it aims to answer are

1. Is ICU care-provider initiated written communication feasible and acceptable to participants?
2. Does ICU care-provider initiated written communication affect the experience of families and care providers?

Participants will complete surveys and participate in interviews during a 3 month pre-implementation phase and a 3 month post-implementation phase

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.